Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fate Therapeutics
(NQ:
FATE
)
2.000
-0.120 (-5.66%)
Streaming Delayed Price
Updated: 11:02 AM EDT, Oct 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fate Therapeutics
< Previous
1
2
3
4
5
Next >
Analyst Ratings for Fate Therapeutics
September 07, 2023
Via
Benzinga
The Latest Analyst Ratings for Fate Therapeutics
August 16, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
Why Shares of Fate Therapeutics Soared This Week
June 16, 2023
The company's shares bounced back after a stock sale last week.
Via
The Motley Fool
Where Fate Therapeutics Stands With Analysts
May 05, 2023
Via
Benzinga
Fate Therapeutics: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Fate Therapeutics Earnings Preview
May 02, 2023
Via
Benzinga
15 Analysts Have This to Say About Fate Therapeutics
March 27, 2023
Via
Benzinga
$1.7M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
April 24, 2023
Although US stocks closed slightly higher on Friday, there were a few notable insider trades.
Via
Benzinga
Expert Ratings for Fate Therapeutics
March 01, 2023
Via
Benzinga
Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 14, 2023
Don’t forget to check out our premarket coverage here Fate Therapeutics, Inc. (NASDAQ: FATE) fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday,...
Via
Benzinga
Sorrento Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 13, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
5 Cheapest Health Care Stocks You Should Think About
January 27, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Analyst Ratings for Fate Therapeutics
January 24, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
Via
Benzinga
5 Health Care Stocks That Are Diving - And May Rally
January 19, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Over $10 Million Bet On DiamondHead Holdings? Check Out These 4 Stocks Insiders Are Buying
January 17, 2023
Although US stocks closed higher on Friday, there were a few notable insider trades.
Via
Benzinga
Top 5 Health Care Stocks That May Surge
January 10, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
How Is The Market Feeling About Fate Therapeutics?
January 09, 2023
Fate Therapeutics's (NASDAQ:FATE) short percent of float has fallen 4.62% since its last report. The company recently reported that it has 20.24 million shares sold short, which is 27.85% of all...
Via
Benzinga
CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC
January 06, 2023
Gene-editing stocks have not been immune when it comes to job losses and workforce reductions. Here are a few of the latest.
Via
InvestorPlace
Dow Jumps 700 Points; S&P 500 Rises Over 2%
January 06, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
Via
Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
January 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 06, 2023
During Friday's trading, 71 companies set new 52-week lows.
Via
Benzinga
Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday
January 06, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Is Fate Therapeutics (FATE) Stock Down 62% Today?
January 06, 2023
Fate Therapeutics (FATE) stock is falling on Friday after the company announced the termination of its collaboration with Janssen Biotech.
Via
InvestorPlace
Tesla Falls Again, but This Nasdaq Stock Is Truly Plunging
January 06, 2023
The Nasdaq Composite once again is underperforming the rest of the market.
Via
The Motley Fool
Fate Therapeutics Ends Collaboration Deal With Janssen, Cuts Staff
January 06, 2023
Via
Benzinga
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
January 06, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.